<DOC>
	<DOCNO>NCT01982968</DOCNO>
	<brief_summary>This study test hypothesis treatment laparoscopic anti-reflux surgery subject idiopathic pulmonary fibrosis ( IPF ) abnormal gastroesophageal reflux ( GER ) slow decline force vital capacity ( FVC ) 48 week .</brief_summary>
	<brief_title>Treatment IPF With Laparoscopic Anti-Reflux Surgery</brief_title>
	<detailed_description />
	<mesh_term>Fibrosis</mesh_term>
	<mesh_term>Gastroesophageal Reflux</mesh_term>
	<mesh_term>Pulmonary Fibrosis</mesh_term>
	<mesh_term>Idiopathic Pulmonary Fibrosis</mesh_term>
	<mesh_term>Idiopathic Interstitial Pneumonias</mesh_term>
	<criteria>Confirmed diagnosis idiopathic pulmonary fibrosis Abnormal GER 24hour pH monitoring ( DeMeester score &gt; 14.7 ) Able provide inform consent Willing undergo laparoscopic antireflux surgery FVC &lt; 50 % predict FEV1/FVC ratio &lt; 0.65 Resting room air PaO2 &lt; 60mm Hg Unable walk 50 meter 6 minute walk test Acute respiratory illness last 12 week Experimental medication IPF last 28 day Listed lung transplantation screen Unable safely undergo surgery History esophageal / bariatric / gastric surgery History cancer ( nonmelanoma skin cancer ) last 3 year Pregnant time screen enrollment Unable obtain preauthorized approval third party payer surgery relate cost Life expectancy &lt; 48 week due another illness BMI &gt; 35 Known severe pulmonary hypertension ( mean pressure &gt; 35 mm Jg RHC ; RVSP &gt; 50 mm Hg ECHO )</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>Idiopathic pulmonary fibrosis</keyword>
	<keyword>IPF</keyword>
	<keyword>Gastroesophageal reflux</keyword>
	<keyword>GER</keyword>
	<keyword>GERD</keyword>
</DOC>